Literature DB >> 17310995

Structure of the C-terminal MA-3 domain of the tumour suppressor protein Pdcd4 and characterization of its interaction with eIF4A.

L C Waters1, V Veverka, M Böhm, T Schmedt, P T Choong, F W Muskett, K-H Klempnauer, M D Carr.   

Abstract

Programmed cell death protein 4 (Pdcd4) is a novel tumour suppressor protein, which is involved in the control of eukaryotic transcription and translation. The regulation of translation involves specific interactions with eukaryotic initiation factor (eIF)4A and eIF4G, which are mediated via the two tandem MA-3 domains. We have determined the structure of the C-terminal MA-3 domain of Pdcd4 (Pdcd4 MA-3(C)), characterized its interaction with eIF4A and compared the features of nuclear magnetic resonance (NMR) spectra obtained from the single domain and tandem MA-3 region. Pdcd4 MA-3(C) is composed of three layers of helix-turn-helix hairpins capped by a single helix and shows close structural homology to the atypical HEAT repeats found in many eIFs. The sequence conservation and NMR data strongly suggest that the tandem MA-3 region is composed of two equivalent domains connected by a somewhat flexible linker. Pdcd4 MA-3(C) was found to interact with the N-terminal domain of eIF4A through a conserved surface region encompassing the loop connecting alpha5 and alpha6 and the turn linking alpha3 and alpha4. This site is strongly conserved in other MA-3 domains known to interact with eIF4A, including the preceding domain of Pdcd4, suggesting a common mode of binding.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17310995     DOI: 10.1038/sj.onc.1210305

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  26 in total

1.  Crystal structure of the eIF4A-PDCD4 complex.

Authors:  Jeong Ho Chang; Yong Hyun Cho; Sun Young Sohn; Jung Min Choi; Ahreum Kim; Young Chang Kim; Sung Key Jang; Yunje Cho
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-09       Impact factor: 11.205

2.  Characterization of the structural features and interactions of sclerostin: molecular insight into a key regulator of Wnt-mediated bone formation.

Authors:  Vaclav Veverka; Alistair J Henry; Patrick M Slocombe; Andrew Ventom; Barbara Mulloy; Frederick W Muskett; Mariusz Muzylak; Kevin Greenslade; Adrian Moore; Li Zhang; Jianhua Gong; Xueming Qian; Chris Paszty; Richard J Taylor; Martyn K Robinson; Mark D Carr
Journal:  J Biol Chem       Date:  2009-02-10       Impact factor: 5.157

3.  High resolution NMR-based model for the structure of a scFv-IL-1beta complex: potential for NMR as a key tool in therapeutic antibody design and development.

Authors:  Ian C Wilkinson; Catherine J Hall; Vaclav Veverka; Jiye Y Shi; Frederick W Muskett; Paul E Stephens; Richard J Taylor; Alistair J Henry; Mark D Carr
Journal:  J Biol Chem       Date:  2009-09-23       Impact factor: 5.157

4.  Enhanced arginine methylation of programmed cell death 4 protein during nutrient deprivation promotes tumor cell viability.

Authors:  Marta M Fay; James M Clegg; Kimberly A Uchida; Matthew A Powers; Katharine S Ullman
Journal:  J Biol Chem       Date:  2014-04-24       Impact factor: 5.157

5.  Tumor suppressor protein Pdcd4 inhibits translation of p53 mRNA.

Authors:  Lena Wedeken; Priyanka Singh; Karl-Heinz Klempnauer
Journal:  J Biol Chem       Date:  2011-10-27       Impact factor: 5.157

6.  Mycobacterium tuberculosis RNA polymerase-binding protein A (RbpA) and its interactions with sigma factors.

Authors:  Alessio Bortoluzzi; Frederick W Muskett; Lorna C Waters; Philip W Addis; Barbara Rieck; Thomas Munder; Susanne Schleier; Francesca Forti; Daniela Ghisotti; Mark D Carr; Helen M O'Hare
Journal:  J Biol Chem       Date:  2013-04-02       Impact factor: 5.157

7.  Conformational heterogeneity in antibody-protein antigen recognition: implications for high affinity protein complex formation.

Authors:  Philip W Addis; Catherine J Hall; Shaun Bruton; Vaclav Veverka; Ian C Wilkinson; Frederick W Muskett; Philip S Renshaw; Christine E Prosser; Bruce Carrington; Alastair D G Lawson; Robert Griffin; Richard J Taylor; Lorna C Waters; Alistair J Henry; Mark D Carr
Journal:  J Biol Chem       Date:  2014-01-16       Impact factor: 5.157

8.  Resonance assignment and secondary structure of the middle MA-3 domain and complete tandem MA-3 region of the tumour suppressor protein Pdcd4.

Authors:  Lorna C Waters; Ojore Oka; Frederick W Muskett; Sarah L Strong; Thore Schmedt; Karl-Heinz Klempnauer; Mark D Carr
Journal:  Biomol NMR Assign       Date:  2009-12-19       Impact factor: 0.746

9.  Programmed cell death 4 loss increases tumor cell invasion and is regulated by miR-21 in oral squamous cell carcinoma.

Authors:  Patricia P Reis; Miranda Tomenson; Nilva K Cervigne; Jerry Machado; Igor Jurisica; Melania Pintilie; Mahadeo A Sukhai; Bayardo Perez-Ordonez; Reidar Grénman; Ralph W Gilbert; Patrick J Gullane; Jonathan C Irish; Suzanne Kamel-Reid
Journal:  Mol Cancer       Date:  2010-09-10       Impact factor: 27.401

10.  PDCD4 inhibits translation initiation by binding to eIF4A using both its MA3 domains.

Authors:  Chikako Suzuki; Robert G Garces; Katherine A Edmonds; Sebastian Hiller; Sven G Hyberts; Assen Marintchev; Gerhard Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-22       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.